[1]FDA approves the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors. Retrieved January 9, 2020, from https://www.fda.gov/news-events/press-announcements/fda-approves-first.....
[1] ADC Therapeutics Announces Positive Results from Pivotal Phase 2 Clinical Trial of Single Agent Loncastuximab Tesirine (ADCT-402) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma,Retrieved Janua.....
[1] US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma,Retrieved January 21, 2020, from https://www.prnewswire.com/news-release.....
作者:刘双又 单位:北京博仁医院来源:肿瘤资讯2020年2月6日,国际血液学领域权威期刊Blood Cancer Journal发表了一篇来自中国题为《Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for.....